- Home
- COOK vs PRME Comparison
COOK vs PRME Comparison
Compare COOK & PRME Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- COOK
- PRME
- Stock Information
- Founded
- COOK 1985
- PRME 2019
- Country
- COOK United States
- PRME United States
- Employees
- COOK N/A
- PRME N/A
- Industry
- COOK Wholesale Distributors
- PRME Medicinal Chemicals and Botanical Products
- Sector
- COOK Consumer Discretionary
- PRME Health Care
- Exchange
- COOK Nasdaq
- PRME Nasdaq
- Market Cap
- COOK 255.1M
- PRME 191.7M
- IPO Year
- COOK 2021
- PRME 2022
- Fundamental
- Price
- COOK $1.91
- PRME $4.48
- Analyst Decision
- COOK Buy
- PRME Buy
- Analyst Count
- COOK 7
- PRME 6
- Target Price
- COOK $2.43
- PRME $9.38
- AVG Volume (30 Days)
- COOK 735.0K
- PRME 4.3M
- Earning Date
- COOK 08-05-2025
- PRME 08-04-2025
- Dividend Yield
- COOK N/A
- PRME N/A
- EPS Growth
- COOK N/A
- PRME N/A
- EPS
- COOK N/A
- PRME N/A
- Revenue
- COOK $602,441,000.00
- PRME $3,846,000.00
- Revenue This Year
- COOK $0.06
- PRME $104.12
- Revenue Next Year
- COOK $3.18
- PRME $196.78
- P/E Ratio
- COOK N/A
- PRME N/A
- Revenue Growth
- COOK 0.80
- PRME 550.76
- 52 Week Low
- COOK $1.28
- PRME $1.11
- 52 Week High
- COOK $3.97
- PRME $6.75
- Technical
- Relative Strength Index (RSI)
- COOK 63.05
- PRME 88.59
- Support Level
- COOK $1.81
- PRME $2.28
- Resistance Level
- COOK $1.98
- PRME $4.21
- Average True Range (ATR)
- COOK 0.10
- PRME 0.42
- MACD
- COOK 0.01
- PRME 0.22
- Stochastic Oscillator
- COOK 90.32
- PRME 96.69
About COOK Traeger Inc.
Traeger Inc designs, sources, sells, and supports wood pellet fueled barbeque grills sold to retailers, distributors, and direct to consumers. It produces and sells the pellets used to fire the grills and also sells Traeger-branded rubs, spices, and sauces, as well as grilling accessories including covers, barbeque tools, trays, liners, and merchandise. The company's geographical segments include North America and the Rest of the world, of which majority of revenue is from North America.
About PRME Prime Medicine Inc.
Prime Medicine Inc is a biotechnology company committed to delivering genetic therapies to address diseases by deploying gene editing technology, Prime Editing. The Prime Editing technology is a next-generation technology that can search and replace to restore normal genetic function in the genome and can treat a wide spectrum of diseases with high unmet medical needs and efficient and broad gene editing technology.